Pay in 4 interest-free payments of $6.69 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Melanotan 2 at a Glance Melanotan 2 (alpha-MSH Analog) Type: Synthetic analog of alpha-MSH | Primary Target: MC1R (melanocortin 1 receptor) | Secondary Targets: MC3R, MC4R, MC5R | Primary Effect: Skin darkening (eumelanin production) | Secondary Effects: Sexual arousal, appetite suppression | Route: Subcutaneous injection | FDA Status: Not approved | Related: PT-141 (bremelanotide), derived from MT-2 research MT-2 was originally developed at the University of Arizona in the 1990s as a potential preventive treatment for skin cancer
If Natco wins, it can sell a much cheaper option, reach more patients, and gain a strong place in the fast-growing weight-loss drug market
However, Novo Nordisk is expected to emerge as the leading company, having a large portfolio of GLP1 drugs, and is expected to capture 55 per cent of the market share in 2029.
The combination addresses both insulin resistance (metformin) and appetite signaling dysfunction (GLP-1), creating complementary metabolic benefits for patients with obesity and type 2 diabetes
50 ml Hyaluronic Acid
US$ 23.11
US$ 24.18
US$ 29.91
US$ 24.86
